2024 Applied therapeutics stock

NEW YORK, Nov. 12, 2019 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (NASDAQ: APLT) (the “Company”), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced it has entered into a definitive securities purchase …Applied Therapeutics Inc Stock forecast & analyst price target predictions based on 2 analysts offering 12-months price targets for APLT in the last 3 months.Jan 3, 2024 · Grandbrothers. Applied Therapeutics (NASDAQ:APLT) stock jumped 10% in late morning trading Wednesday after the company said it has submitted applications for FDA and EU approval of its drug ... In today’s fast-paced world, finding activities that provide relaxation and a sense of accomplishment is more important than ever. One such activity that has gained popularity in r...NEW YORK, June 22, 2022 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (NASDAQ: APLT) (the “Company”), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced the pricing of its underwritten public offering of …Feb 15, 2024 · Applied Therapeutics ( NASDAQ: APLT) rose ~14% premarket Thursday after the biotech said its Phase 3 INSPIRE trial for lead candidate govorestat (AT-007) reached main goals against a rare ... Historical daily share price chart and data for Applied Therapeutics since 2019 adjusted for splits and dividends. The latest closing stock price for Applied Therapeutics as of January 12, 2024 is 2.50.. The all-time high Applied Therapeutics stock closing price was 55.47 on February 05, 2020.; The Applied Therapeutics 52-week high stock price is 4.42, which …Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical company which engages in the development of a pipeline of novel products.Which technical analysis tools can be used to analyze Applied Therapeutics, Inc.? Check out various oscillators, moving averages and other technical ...1.22M. 109.87%. Get the latest Applied Therapeutics Inc (APLT) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and ... Applied Therapeutics Inc stock price live 5.66, this page displays NASDAQ APLT stock exchange data. View the APLT premarket stock price ahead of the market session or assess the after hours quote.NEW YORK, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated ...Applied Therapeutics Announces Topline Results from the ARISE-HF Phase 3 Study of AT-001 in Diabetic Cardiomyopathy. AT-001 (caficrestat) demonstrated a strong trend in stabilizing cardiac functional capacity, while the placebo group declined over 15 months AT-001 treatment resulted in a statistically significant difference in cardiac functional capacity …Jan 3, 2024 · Grandbrothers. Applied Therapeutics (NASDAQ:APLT) stock jumped 10% in late morning trading Wednesday after the company said it has submitted applications for FDA and EU approval of its drug ... What this means: Applied Therapeutics Inc. (APLT) gets a very positive evaluation from InvestorsObserver's ranking system. An Overall Rank of 91 means that our comprehensive methodology rates Applied Therapeutics Inc. above 91% of stocks. Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental …Riccardo Perfetti, M.D., Ph.D. has served as Chief Medical Officer of Applied Therapeutics since August 2018. Before joining us, Dr. Perfetti served as a Senior Medical Officer, Vice President and Head of Global Medical Affairs, Diabetes and Cardiovascular Business Unit at Sanofi S.A., a publicly traded pharmaceutical company, from October 2007 to August 2018.NEW YORK, Jan. 21, 2020 -- Applied Therapeutics, Inc. , a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications...Company profile page for Applied Therapeutics Inc including stock price, company news, executives, ... Applied Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company.By Colin Kellaher . Applied Therapeutics shares rose sharply and hit a new 52-week high on Wednesday after the clinical-stage biopharmaceutical company reported a pair of regulatory advances for its lead product candidate.Applied Therapeutics Inc. analyst ratings, historical stock prices, ... Actuals & Estimates Applied Therapeutics Inc. Quarterly; Annual; Actual Analyst Range Consensus. 0.20 0.00-0.20-0.40. Actual ...APLT: Applied Therapeutics Inc Stock Price Quote - NASDAQ GM - Bloomberg. Bloomberg. Connecting decision makers to a dynamic network of information, people …The PE Ratio as of February 2024 (TTM) for Applied Therapeutics, Inc. ( APLT) is -4.10. According to Applied Therapeutics, Inc. ’s latest financial reports and current stock price. The company's current PE Ratio is -4.10. This represents a change of 253.73% compared to the average of -1.16 of the last 4 quarters.Get the latest stock price, quote, news and history of Applied Therapeutics, Inc. Common Stock (APLT), a biotechnology company that develops and commercializes oncology products. See real-time data, market cap, key data and news of APLT on Nasdaq. Applied Therapeutics, Inc. (APLT) latest earnings report: revenue, EPS, surprise, history, news and analysis.NEW YORK, April 24, 2023 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (NASDAQ: APLT) (the “Company”), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced it has entered into a definitive securities purchase …1.22M. 109.87%. Get the latest Applied Therapeutics Inc (APLT) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and ... Long-term APLT price forecast for 2025, 2030, 2035, 2040, 2045 and 2050. Our analysts are offering long term price forecasts for Applied Therapeutics Inc In 2050, the median target price for APLT is $ 2.8103, with a high estimate of $ 32.08 and a low estimate of $ 0.1441. The median estimate represents a -50.08% decrease from the last price of ...Apr 24, 2023 · Applied Therapeutics, Inc. Announces $30 Million Private Placement of Equity. NEW YORK, April 24, 2023 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (NASDAQ: APLT) (the “Company”), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet ... Fintel reports that on February 22, 2024, Leerink Partners initiated coverage of Applied Therapeutics (NasdaqGM:APLT) with a Outperform recommendation. As of …Jan 5, 2024 · Applied Therapeutics (NASDAQ:APLT) stock is falling on Friday following the release of Phase 3 clinical trial data from the clinical-stage biopharmaceutical company. Find the latest Applied Therapeutics, Inc. (APLT) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.Applied Therapeutics Inc (ZB_58319995.NASDAQ) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Applied Therapeutics Inc | Nasdaq ... The more transactions an expert has, the more significant the results become. 1. Denali Therapeutics. Markets Insider. Ticker: DNLI. Market cap: $2.49B. …Penny stocks may sound like an interesting investment option, but there are some things that you should consider before deciding whether this is the right investment choice for you...Applied Therapeutics Announces Topline Results from the ARISE-HF Phase 3 Study of AT-001 in Diabetic Cardiomyopathy PRESS RELEASE GlobeNewswire Jan. 4, 2024, 04:05 PMFuture criteria checks 2/6. Applied Therapeutics is forecast to grow earnings and revenue by 14% and 79.2% per annum respectively. EPS is expected to grow by 22.3% per annum. Return on equity is forecast to be -229.5% in 3 years.Jan 4, 2024 · GreenApple78. Applied Therapeutics (NASDAQ:APLT) stock plunged 30% in post-market trading Thursday after the biotech company reported mixed results from a Phase 3 study of its drug AT-001 and said ... Applied Therapeutics Inc stock performance at a glance. Check Applied Therapeutics Inc’s past financial performance, like revenue or net income, plus the top level summary of its past and current market value. APLT Stock Performance. USD USD; Previous close: 3.75: 3.75: Day range: 3.73 - 5.833.73 - 5.83Year range: 0 - 50 - 5APLT shares declined -10.4% the day following the earnings announcement to close at 2.07. Following its earnings release, 100 days ago, APLT stock has drifted + ...Applied Therapeutics is building a pipeline of novel drugs to treat diseases with no treatment options. Our Aldose Reductase Inhibitor (ARI) franchise is in development across multiple disease areas, including Galactosemia, Diabetic Cardiomyopathy , Diabetic Peripheral Neuropathy and other diseases. The company’s preclinical pipeline also ... By Colin Kellaher . Applied Therapeutics shares rose sharply and hit a new 52-week high on Wednesday after the clinical-stage biopharmaceutical company reported a pair of regulatory advances for its lead product candidate.About Applied Therapeutics. Applied Therapeutics is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need. ... Stock Applied Therapeutics, Inc. - Nasdaq ...545 Fifth Ave. Suite 1400, New York, NY 10017. Where is Applied Therapeutics incorporated? When was Applied Therapeutics founded? Which stock exchange are Applied Therapeutics shares traded on and what is the company’s ticker? When did the company go public? Who is Applied Therapeutics’ transfer agent? What is Applied …Applied Therapeutics' phase 3 INSPIRE study using govorestat for treatment of patients with SORD deficiency achieved. Read why I rate APLT stock a buy.5 days ago ... The 100 rating InvestorsObserver gives to Applied Therapeutics Inc (APLT) stock puts it near the top of the Healthcare sector.Business description. Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against ...Applied Therapeutics Stock Forecast, APLT stock price prediction. Price target in 14 days: 6.772 USD. The best long-term & short-term Applied Therapeutics ...Get a real-time Applied Therapeutics, Inc. (APLT) stock price quote with breaking news, financials, statistics, charts and more.Jan 4, 2024 · Applied Therapeutics leverages technological advances to target molecules and pathways with proven roles in disease biology, new FDA guidance for the use of biomarkers, as well as established clinical endpoints, to bring products to market. This approach can accelerate time from clinical development to approval, and into the hands of patients ... NEW YORK, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced it has submitted a New Drug Application (NDA) to the U.S. Food and …In today’s fast-paced world, finding activities that provide relaxation and a sense of accomplishment is more important than ever. One such activity that has gained popularity in r...Sponsored Content. Applied Therapeutics Inc (NASDAQ:APLT) shares are trading higher after the company, on Thursday, released interim 12-month results from the ongoing Phase 3 INSPIRE trial, in ... Jan 5, 2024 ... Applied Therapeutics' stock market winning streak has come to an end. Having seen its shares soar over the past year, the biotech suffered a ...Applied Therapeutics Inc (ZB_58319995.NASDAQ) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Applied Therapeutics Inc | Nasdaq ... NEW YORK, June 22, 2022 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (NASDAQ: APLT) (the “Company”), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates ...5 days ago ... The 100 rating InvestorsObserver gives to Applied Therapeutics Inc (APLT) stock puts it near the top of the Healthcare sector.38,627.99. -145.11(-0.37%) Nasdaq. 15,775.65. -130.55(-0.82%) Russell 2000. 2,032.74. -28.74(-1.39%) Crude Oil. 78.83. -0.36(-0.45%) Gold. 2,030.20. +6.10(+0.30%) Applied …Dec 17, 2019 ... Lyanne Alfaro is joined by Shoshana Shendelman who is the President & CEO of Applied Therapeutics. They sit down ... CRSP Stock On Wild Ride After ...APLT stock opened at $5.13 on Thursday. The business has a fifty day moving average price of $3.10 and a 200 day moving average price of $2.44. Applied Therapeutics has a fifty-two week low of $0.76 and a fifty-two week high of $6.00. The stock has a market capitalization of $396.19 million, a price-to-earnings ratio of -4.35 and a beta of 1.53.Nowadays finding high-quality stock photos for personal or commercial use is very simple. You just need to search the photo using a few descriptive words and let Google do the rest...If you need cash, aren’t happy with your investment returns or want to diversify your investments, you may have to liquidate some of your stocks. Buying and selling stocks is extre...NEW YORK, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced successful completion of a recent pre-New Drug Application (“NDA”) …NEW YORK, Nov. 12, 2019 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (NASDAQ: APLT) (the “Company”), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced it has entered into a definitive securities purchase …Feb 15, 2024 · Applied Therapeutics ( NASDAQ: APLT) rose ~14% premarket Thursday after the biotech said its Phase 3 INSPIRE trial for lead candidate govorestat (AT-007) reached main goals against a rare ... By Colin Kellaher . Applied Therapeutics shares rose sharply and hit a new 52-week high on Wednesday after the clinical-stage biopharmaceutical company reported a pair of regulatory advances for its lead product candidate.Jan 4, 2024 · Applied Therapeutics is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need. The Company’s lead drug candidate, AT-007, is a novel central nervous system penetrant Aldose Reductase Inhibitor (ARI) for the treatment of CNS rare ... 78.27. +0.09(+0.12%) Gold. 2,035.50. -4.30(-0.21%) Applied Therapeutics, Inc. (APLT) NasdaqGM - NasdaqGM Real Time Price. Currency in USD. Follow. 2W 10W 9M. 5.31 -0.07 (-1.30%) At close:...Get the latest Applied Therapeutics Inc (APLT) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and …Get the latest stock price, quote, news and history of Applied Therapeutics, Inc. Common Stock (APLT), a biotechnology company that develops and commercializes oncology products. See real-time data, market cap, key data and news of APLT on Nasdaq. Applied Therapeutics Inc Stock forecast & analyst price target predictions based on 2 analysts offering 12-months price targets for APLT in the last 3 months.Information on stock, financials, earnings, subsidiaries, investors, and executives for Applied Therapeutics. Use the PitchBook Platform to explore the full ...Long-term APLT price forecast for 2025, 2030, 2035, 2040, 2045 and 2050. Our analysts are offering long term price forecasts for Applied Therapeutics Inc In 2050, the median target price for APLT is $ 2.8103, with a high estimate of $ 32.08 and a low estimate of $ 0.1441. The median estimate represents a -50.08% decrease from the last price of ...The following information was filed by Applied Therapeutics Inc. (APLT) on Thursday, March 23, 2023 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the …Career Opportunities. At Applied Therapeutics, we are passionate about our mission to develop transformative treatments for patients with high unmet medical need. Applied Therapeutics is dynamic company built on the foundational values of trust, respect, empathy, creativity, quality, integrity and collaboration. Our team is exactly that – a ...Jan 5, 2024 ... Applied Therapeutics shares dipped 35.6% to $2.4498 on Friday. Here are some other stocks moving in today's mid-day session. Gainers. Ainos, Inc ...See Applied Therapeutics, Inc. (APLT) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.Feb 16, 2024 ... Indeed, Applied Therapeutics (NASDAQ:APLT) stock is up 221% in the last year, providing strong gains for shareholders. Having said that ...Nov 5, 2023 · Our most recent data indicates that insiders own some shares in Applied Therapeutics, Inc.. As individuals, the insiders collectively own US$9.8m worth of the US$150m company. Career Opportunities. At Applied Therapeutics, we are passionate about our mission to develop transformative treatments for patients with high unmet medical need. Applied Therapeutics is dynamic company built on the foundational values of trust, respect, empathy, creativity, quality, integrity and collaboration. Our team is exactly that – a ...Applied Therapeutics stock is tumbling on Friday as investors react to lackluster results from a Phase 3 clinical trial of AT-001.More From InvestorPlace The #1 AI Investment Might Be This Company ... Nov 5, 2023 · Our most recent data indicates that insiders own some shares in Applied Therapeutics, Inc.. As individuals, the insiders collectively own US$9.8m worth of the US$150m company. Applied Therapeutics (APLT) News Today. $2.68. -0.04 (-1.47%) (As of 02/14/2024 ET) Stock Analysis Analyst Forecasts Chart Competitors Earnings Financials Headlines Insider Trades Options Chain Ownership SEC Filings Short Interest Social Media Sustainability. Source. Sentiment All Sentiments. Source. Headline.Jan 30, 2024 · Applied Therapeutics, Inc. (APLT.NASDAQ): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Applied Therapeutics, Inc. | Nasdaq: APLT ... APLT - Applied Therapeutics Inc Stock Price and Quote. Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools. APLT. Applied …Applied Therapeutics Stock Forecast. All Analysts Top Analysts Stock Price Forecast. The 2 analysts with 12-month price forecasts for APLT stock have an average target of 10.5, with a low estimate of 7.00 and a high estimate of 14. The average target predicts an increase of 95.17% from the current stock price of 5.38.Jan 4, 2022 ... The New York drug maker hired a lawyer to find the people shorting its stock and to scare them into silence.Stock Quote & Chart | Applied Therapeutics. Change. Volume. Today's Open. Previous Close. Today's High. Today's Low. 52 Week High. 52 Week Low. Stock Chart. EGRX. …5 days ago ... The 100 rating InvestorsObserver gives to Applied Therapeutics Inc (APLT) stock puts it near the top of the Healthcare sector.If you need cash, aren’t happy with your investment returns or want to diversify your investments, you may have to liquidate some of your stocks. Buying and selling stocks is extre...You may have a lot of questions if you are interested in investing in the stock market for the first time. One question that beginning investors often ask is whether they need a br...NEW YORK, June 22, 2022 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (NASDAQ: APLT) (the “Company”), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates ...Information on stock, financials, earnings, subsidiaries, investors, and executives for Applied Therapeutics. Use the PitchBook Platform to explore the full ...

Applied Therapeutics Inc. Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company was founded by Shoshana Shendelman on January 20, 2016 and is headquartered in New …. Prime source foods

1 day ago · 7 Stocks to Buy and Hold Forever. Shares of APLT opened at $5.74 on Thursday. Applied Therapeutics has a 12 month low of $0.76 and a 12 month high of $6.00. The firm has a fifty day simple moving ... Applied Therapeutics Inc. Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company was founded by Shoshana Shendelman on January 20, 2016 and is headquartered in New …The more transactions an expert has, the more significant the results become. 1. Denali Therapeutics. Markets Insider. Ticker: DNLI. Market cap: $2.49B. …NEW YORK, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a p...Applied Therapeutics is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need.In health-care professions, “therapeutic use of self” describes the ability of a caregiver to use his or her personality “consciously and in full awareness in an attempt to establi...Complete Applied Therapeutics Inc. stock information by Barron's. View real-time APLT stock price and news, along with industry-best analysis. Business description. Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against ...Currently, Applied Therapeutics stock is climbing 16.04 percent, to $3.11 over the previous close of $2.68 on a volume of 3,752,156. It had traded between $0.757 and $4.42 for the past 52 weeks on ...Jan 5, 2024 ... Applied Therapeutics shares dipped 35.6% to $2.4498 on Friday. Here are some other stocks moving in today's mid-day session. Gainers. Ainos, Inc ...NEW YORK, Jan. 28, 2020 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (NASDAQ: APLT) (the “Company”), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced it has completed its public offering of 3,152,712 …PRE-FUNDED COMMON STOCK PURCHASE WARRANT Applied Therapeutics, Inc. 10-13 - 1 view Applied Therapeutics Reports Second Quarter 2023 Financial Results Regulatory progress for govorestat (AT-007) for the treatment of Classic Galactosemia, with potential NDA submission based on discussions with the FDA as well ….

You may have a lot of questions if you are interested in investing in the stock market for the first time. One question that beginning investors often ask is whether they need a br...

Applied therapeutics stock - About Applied Therapeutics. Applied Therapeutics is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need. ... Stock Applied Therapeutics, Inc. - Nasdaq ...

Popular Topics